MARKETING PLAN – 2021

NIRVANA LIFE “NL” – Parent Company of Vedic Ways

▪ SYNOPSIS
- What NL offer
NL offer and produce the finest and cleanest high quality THC Medical Flowers
on the legal market. With some of the highest THC genetics in the world
available today. NL have thousands of different pre – tested female seeds. 90%
of these are highly desirable and rare and either unreleased or long lost. This
puts us in a niche market area free of competition. No one else has majority
of these strains.

NL are the sole holders of the most potent cannabis strains in the world,
Chiquita Banana, including 9 different hybrid versions of it.
Our technology guarantees 100% pure quality completely bacteria and
pathogens free. No other company on the market can offer such
guarantees. NL can harvest a crop and have it dry and packed, ready for
shipping within 12 hours. Using technology no one else can match. Normally
the drying and curing process for Cannabis plants is 4-8 weeks. The
technology NL use can also extract Terpenes in the drying process.

NL can also offer individual companies a choice of genetics exclusively if

required. A portfolio of different strains with relevant cannabinoid
information, Terpenes profiles and general areas of health use can be
provided to potential customers.
▪ INTRODUCTION
During the prohibition period NL worked solidly on the underground
creating Seed stock. Some of the seeds were made by Opiate
prescription addicts to wean themselves off the drug which proved
very successful in the late 90s. In the early days serious arguments
broke out and sometimes turned out fatal over seed stock
hermaphrodite and contaminating the entire grow with Male pollen.
This rendered the crop useless for the Black Market. The same goes
for the legal markets now.

NL had to find a solution to stabilise the female seed. This was done
by planting at least 100 seeds minimum of the same genetic. From
these planted seeds certain varietals was hunted out and selected
that was showing certain desired traits i.e., plant height, potency,
Terpene fragrance and yield.

The selected plants are then collected and feminised using certain
techniques, so you are guaranteed female flowers the whole crop. To
get a good stable female Sl takes a few separates grows and tweaks.
Usually, a 3-to-5-year process sometimes longer to fully stabilise a
female Cannabis plant. They can quickly turn "Asexual " if conditions
suddenly change or they get damaged hence you need solid
performing stable specimens that can handle a bit of rough treatment.
Therefore, when you see "professional" companies boasting they have
65 different varieties and planting 5 seeds of each. This is untrue and
unwarranted and simply a complete waste of time by these companies.
These so-called companies are no competition for us, nor do they even
come close to what we have and can do.
▪ SEED STOCK
Most of our Genetic library is already feminised. NL have all the original
building blocks of the modern strains nobody else has.

As an example, most modern strains have Chemdog in the genetic make-up

and not the ChemDawg variant, which is the other version created, because
the original Chemdog was lost, through a trusted grow hand stealing Chems
plants, whilst he was in prison for cultivation of Cannabis.

NL have all Chems original genetics he gifted to his neighbour Jimmy Nitz of
Pisces Genetics. NL have the original Guava Chem, ChemDog, TresDog, Giesel,
Sour Diesel, MotorBreath, Bubble-gum Queen. You can look the world over
but will not find these anywhere.

NL have quite a lot of these rare unable to get hold of strains no one has
anymore. Another example is NL have Snoop Dogs Abusive OG. He doesn't
have this himself no more and was lost in the early OOS California fires. Lots
of these rare specimens NL hold.

The modern cannabis consumer demands new flavours and tastes of which NL
can more than provide for years to come without worry.

Just a small selection of other rare seed/ strains NL have includs but not
limited to the below:

 Mullumbimby Madness.
 FPOG OG
 Coca-Cola OG
 Cherry AK47
 WTF
 Pie Guy of Cookie Fam original Girl Scout Cookies.
  The one you see around is called the Forum cut of GSC and not
the original GSC made by Pie Guy.
 Mylie Cyrus OG
 Charlie Sheen OG
 Woody by Actor Woody Harrelson 4 Horsemen
irukandji Gelato Acai
 Oreos
 Ginger Biscuits
 Triple Chocolate Thai by Drawoh.
 Buckeye Purple
 Pink Runtz
 Black Rose
 Bandit OG
 Platinum Kush Breath
 Petrolia Headstash
 Blueberry Sativa very rare as usually it's indica dominant.

These genetics will properly come into effect when the adult market opens
in Europe which it is starting too now. When this happens then NL have
absolutely no competitors in Europe, the same as NL encountered in
California. NL will quickly engulf the European Market if this happens. The
distribution companies that knew of SF, approached him in California as soon
as they heard he had arrived in California with his seed stock.

As an example of how it works between Medical and Adult Cannabis is, say
for example NL use Chiquita Banana for high sativa count Medical Cannabis
run. NL would probably call it CBSIX as a medical name. But for the adult
market it will be Chiquita Banana Sl.

NL can also make on spec, new strains from our library. NL can also provide
and make new lines of 100% Indica,100% Sativa Landrace,60/40 indica
dominant Hybrid 50/50 indica and sativa Hybrid. The Hybrids NL can really
create any combination for medical conditions with more sativa dominant or
Indica dominant strains. So, NL can offer choice as well for tailored strains.
 Other areas where NL are ahead of most competitors in Europe are our
genetic library. Every other company in Europe all use Dutch and Spanish
seed stock. Dutch cannabis always gives hangover and renowned for it.
Spanish seed is poorly produced because the seed companies pay pittance
to poor farmers to produce them. Our stock has no hangover side effects
and all have a clean high and produced with love and care.

▪ Sales and Marketing

Initially NL intend to sell our product as flowers to pharmaceutical companies
but as NL expand, NL will build our own brand and sell some of our strains
under our own brand, which will be exclusive to us.
NL also have plans to open a wellness centre as well as a Hospice and use our
branded products here.
Other advantage NL will have over the American market is the Tax Benefit –
A snippet from the tax bill -
The draft bill outlining Senate Majority Leader Chuck Schumer’s federal
marijuana reform legislation sets a nationwide MJ excise tax that would rise
from 10% to 25% over five years, a top rate that industry officials argue would
be overly burdensome to operators as well as too high to combat illicit
operators.
The Cannabis Administration and Opportunity Act – unveiled earlier this
month as a 163-page “discussion draft” – would legalize marijuana by
removing it from the federal Controlled Substances Act.
That means it would eliminate Section 280E, the provision in the Internal
Revenue Service tax code that prevents marijuana businesses from deducting
the same ordinary business expenses that mainstream industries can.
 But a 25% federal excise tax on marijuana – on top of any state and local taxes
– would hit growers especially hard, quite likely exceeding their savings from
the elimination of 280E, experts said.
You're looking at 50% tax in a couple of years, which will make Isle of Man
more attractive than ever, for the large North America companies. NL predict
that the Isle of Man over the next 4 years could become a major global
cannabis hub, with its Tax and export privileges and foremost exclusivity to NL.
IOM will end up a prized cannabis location for its ease of access to all ports,
tax benefits, exports, and business innovations.

▪ NL Growth Plans:
We are already in talks with several distributors across Europe for pre sales of
our products – either in flower form or processed into our own brand
products. As a rule of thumb, if we were processing these to finished products,
we can double the revenues.
As per our business plan – we will have 8 rooms in the warehouse. In our first
phase we intend to use produce from one room to roll out our own brand
products and the remaining we will be supplying to the distributors.

We have also done an extensive research on the uses of Medicinal Cannabis

for the treatment of Cancer; hence we will be rolling out Kiosks in Oncology
Clinics. Picture yourself sitting in an infusion chair at an Oncology clinic; you
are being treated for stage 2 cancer. You go to your clinic multiples times per
week and sit anxiously in that leather chair for 4 hours while chemo runs
through you. You already have three prescriptions for nausea, two for pain,
and continue to ask the doctor what else can help. While planted in your chair,
you notice a kiosk called Nirvana Life - NL with a tablet that says it can help
avoid more medications while enabling you to cope better. Would you check
it out while at the clinic? We found that 9 of 10 patients will. The current state
of the cannabis market leaves the medicine makers without the ability to get
their products to the patients that actually use it as medicine. Nirvana Life will
allow access to the industry’s best-in-breed medically focused cannabis
products by way of an accurate product recommendation engine and directly
the patient’s home, bypassing the discomfort of the dispensary. NL has plans
to places branded kiosks in oncology clinics that provide information, tools,
and personalized medical-grade cannabis recommendations for patients
seeking relief from treatments. Patients can purchase directly from a tablet,
get connected with a specialized healthcare provider for a one-on-one
professional consultation at a later point, or take their personalized product
recommendation home and explore NL’s fully-vetted products at their own
pace online. Once purchased, our frictionless delivery can get the patient’s
product and usage instructions to them the same day to start providing relief
from nausea, pain, and anxiety. As they continue to experience relief, our
process will seamlessly intake patient details, product usage, and relief levels,
which allows it to intelligently recommend other products that may be more
appropriate if conditions change, and/or reorder so that patients never run
out in the medicine cabinet during a treatment cycle. The patient also
understands the greater good of NL because their anonymous information and
results are integrated into our data engine. This means with every patient our
engine gets smarter, cannabis is more recognized by the healthcare system,
and participants are helping a new patient that is suffering through the same
symptoms. How NL will address problems In the market at our core, NL will
endeavour to tackle the problem of a broken medical cannabis system for
patients and the high-quality, medically-focused manufacturers that make the
medicine. Today, oncology patients undergoing chemotherapy are stuck in an
ineffective, inefficient, and under-educated system. Many of them are on
several prescriptions to help cope with severe nausea, pain and anxiety. In
addition, many patients are nervous about getting addicted to opioids or other
medications they need to take. If a patient does want to try using medical
cannabis for relief, they have limited access to medically focused products
because of legislative hoops and lack of medical-grade cannabis at the
dispensary. In addition, the cost to buy the right legal cannabis products can
be high, so many patients are forced to go to the black market where quality
is inconsistent. Finally, there may be limited transparency on what you are
taking, what you should take based on your symptoms, and how to take it to
get relief. NL helps solves these roadblocks for patients because we
understand the underlying chemistry that goes much deeper than the old
“Sativa” vs “Indica” framework. Instead, we map the terpene and flavonoid
profiles of cannabis strains, understand how it is absorbed into your body
through different methods, and how these elements match with specific
conditions. We provide the patient easy access, transparency, and educate
them about how to use medical-grade cannabis to get relief. For healthcare
providers, the pressure continues to mount to play their part in reducing the
opioid epidemic and our society’s reliance on traditional pharmaceuticals.
However, these same physicians are cornered (and compensated) to
participate in the problem because their patients need help and it is not easy
to offer an alternative like medical-grade cannabis. The pressure on doctors is
only likely to grow and NL offers an easy, trustworthy alternative they can
provide to their patients to reduce the number of prescriptions written.
Kiosk Model Testing To-Date: This model has been tested in two oncology
clinics that have a total of 5,000 patients. By providing only minimal support
and training and a scaled-down version of the kiosk model, the healthcare
providers in that practice readily recommended investigating medical
cannabis to their patients. The overall willingness of the patients at these
clinics has been over 95%. These figures translate to strong unit economics for
each clinic that write up to three prescriptions for anti-nausea for each patient
undergoing chemo treatment alone. Our current estimates based on market
testing shows that if we could replace just one of the three anti-nausea
medications then we could attract hundreds of recurring orders monthly from
each clinic. In addition to exponential growth across the network of current
oncology clinics through our own direct efforts, we are developing
partnerships with GPOs (Group Purchasing Organizations) to gain broader
access to oncology networks at scale. These GPOs are also able to provide
rebates back to clinics when patients purchase through NL, which will assist in
driving mindshare from healthcare providers to recommend exploring our
alternative.
The team that will be accelerating this effort to rapidly scale is made up of
experienced professionals with a range of backgrounds. Their common thread
is a desire to build a business that has a positive societal impact across the
globe, conducting themselves in a manner that keeps the learning curve ahead
of the investment curve in this changing healthcare and cannabis
environment.
The Critical Success Factors in Scaling NL in 2021: As we move forward in
accelerating our business, the team has identified 3 critical success factors that
we are laser focused on:
● First, continue to enhance our model to maximize lifetime value by obtaining
the right results to patients and a seamless customer experience, including a
managed subscription option.
● Second, minimize our cost of customer acquisition by building a streamlined
model of signing up oncology clinics, provide continuous education and
mindshare for healthcare providers ourselves, and leverage partnerships to
help achieve these objectives.
● Third, continue to develop and improve our underlying medical cannabis
knowledge and the connection between conditions, product type, method
taken, and relief to be the thought leader through data and analytics.
We will continue to be laser focused on these 3 elements as we scale our
business because they will not only be foundational to a strong economic
model, but a sustainable leadership position in the industry.
Phase 1 Growth Plan: Our focus is on getting our kiosk into clinics and
educating both the healthcare providers and patients on the relief that
medical-grade cannabis can bring and the ease of NL’s solution. Our objective
for 2021- 2022 is to grow to four or five oncology clinics through leveraging
our current clinic relationships and to add another three to four oncology
practices through strategic partnerships with GPOs that drive access and
awareness. Beyond 2021, there are over thousands practicing oncologists in
Europe where we can focus our efforts. Aside from our focus on Oncology, we
plan to explore what other healthcare professionals are seeking an alternative
to prescribing traditional medications for pain, nausea, or anxiety. Simply
stated, there is significant room to grow across many dimensions once we gain
a stronghold in the Oncology space
Over the course of 2022, we will be supporting the continual enhancement of
6 core capabilities that drive our business model forward.
1. Technical development including the relaunch of our e-commerce and
digital channel that supports a seamless customer experience, integration
code for frictionless delivery with our cannabis delivery partner, and
incremental security to ensure that we are compliant when working with
healthcare professionals and clinic systems
2. Improvement of the intelligent recommendation engine & collection of
efficiency data
3. Inventory purchasing to cover current design territory with the minimal
portfolio
4. Continual education and marketing material development for healthcare
providers and patients
5. Development and support of a direct channel to support accelerating clinic
sign ups 6. Development of 3rd party partnerships to drive greater access to
clinics (e.g., GPOs) as well as improve our ability to deliver tele-health cannabis
consultations through a healthcare provider network

List of Products we can make:

These products can be made and marketed at a later stage after the initial
flower sale to get the funds rolling in:
We can make Medical Pre-Rolls. Using new
technology, we can mass produce these up to 8000
pre rolls in 3 hours. Manufacturing these will double
the price per lb. 8 pre rolls Pack half gram each 4g
total average wholesale price $20

Standard Flowers, loose but trimmed – average price

as of July 2021 $1,945 per lbs

Distillate like Pre-Rolls double your returns per lb.

Average wholesale price per gram $25-30
 We can make CO2 concentrate this doubles
the price per lb return average $20 gram
wholesale.

We can further enhance this to make it more

potent in the form of Diamonds and Sauce
made from distilled THCA and Terpene rich
sauce. Average $30 gram wholesale price.

We can make Shatter from the CO2 by using

certain techniques. Average price per gram
wholesale $25-30.
We can make Live Resin vape carts using certain techniques.
Average price per gram wholesale $30-45.

Live Rosin made using different technologies than

CO2. This fetches more per gram. Average
wholesale price per gram is $35-45.

RSO Full spectrum OIL for Cancer treatment,

Heart Disease, Epilepsy, MS, Liver and Kidney
disease, Appetite loss . Average wholesale price
per gram $20
The above is only a small list of products that we can produce. This is not an
exhaustive list.

NL Future Plans – Besides cultivating and producing world

class Medicinal Cannabis we also plan to open our own consulting firm.
Our planned areas of diversification are:

1. Wellness Centre – Introducing our products

2. Hospice
3. Cannabis Consultancy Firm
4. Cannabis Seminars around the Globe
5. Franchising our Business
6. Tie ups with universities to give lectures on Medicinal Cannabis
7. Lastly, we plan to have an IPO